Try GOLD - Free

Locus Aims To Be A Market Leader In The Healthcare Services Domain

Express Pharma

|

Express Pharma (Vol.12, No.7) February 1-15, 2017

Locus, a machine learning start-up, is helping companies across sectors automate their intra-city scheduled and on-demand delivery, thereby ushering a new paradigm in logistics solutions. Nishith Rastogi, Co-Founder and CEO, Locus, talks about the differentiators that his company offers, the challenges it seeks to address and changing trends in pharma logistics.

- Lakshmipriya Nair

Locus Aims To Be A Market Leader In The Healthcare Services Domain

As a logistics solutions company, how are you different from your counterparts? What are the three major differentiators that you have brought to the table?

Locus is a highly intelligent platform that focusses on decision making. We are not just a software developer but a squad with an ability of solving complicated operational challenges on ground. It is the first automatic dispatch engine to work on the ground and scale as per the industry's wants.

Our routing technology is easily adaptable to several verticals and use cases, right from moving people to packages. From cement to FMCG and the pharma industry where time is of essence, our platform can easily be scaled for cross industry disruption.

Locus’ planning engine concocts highly optimised routing while it envisages constraints like time, volume, etc., taking into account several variables, including real-time gridlock conditions.

What are the most pressing challenges that you seek to overcome in the logistics arena through your solutions?

Let’s categorise these challenges to decipher them better. Productivity vs time is a major challenge that needs to be addressed in logistics. The key current issue is under utilisation of space and resources. Dependency on human resources makes the entire operation sub-optimal. Inefficient logistics leads to increase in overhead and resource costs, which is an alarming sign. The product margins get squeezed and this can make organisations noncompetitive in the market.

MORE STORIES FROM Express Pharma

Express Pharma

Express Pharma

Speed and flexibility play a critical role in how we compete with larger global players

Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Vizag rising: Shaping India's pharma future

At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth

time to read

9 mins

January 2026

Express Pharma

Express Pharma

Future of pharma: Trends, challenges & AI

Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies

time to read

2 mins

January 2026

Express Pharma

Express Pharma

Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments

When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.

time to read

1 mins

January 2026

Express Pharma

Express Pharma

Can Indian biosimilars and generics restate accessibility in global underserved markets?

Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare

time to read

3 mins

January 2026

Express Pharma

Express Pharma

The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers

As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Results win customers. Leadership discipline keeps them

Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.

time to read

3 mins

January 2026

Express Pharma

Express Pharma

INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF

India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge

time to read

8 mins

January 2026

Express Pharma

Express Pharma

PRUV® -The original Sodium Stearyl Fumarate

JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago

time to read

5 mins

January 2026

Express Pharma

Express Pharma

Odisha's pharma pitch

The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury

time to read

5 mins

January 2026

Translate

Share

-
+

Change font size